Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Fidia Spa ( (IT:FDA) ) is now available.
Fidia S.p.A. has announced that Global Growth Holding Limited has converted one bond from the fourth tranche of its reserved convertible bond cum warrant plan, resulting in the issuance of 1,000,000 new shares at a conversion price of €0.01 each. The new shares are admitted directly to trading on the regulated market under an existing prospectus, reinforcing the company’s equity base and progressing the ongoing capital increase linked to the POC facility.
Following this latest conversion, the POC has been subscribed for a nominal €1 million, with €900,000 of the related capital increase already executed and ten bonds still to be converted. As a result, Fidia’s share capital rises by €10,000 to €10,747,761.90 and the total number of shares increases to 49,542,927, modestly diluting existing shareholders while supporting the company’s financial structure and growth initiatives.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global player in numerical control technology and integrated high-performance milling systems. Its solutions, including numerical controls, high-speed milling machines and CAM software, are used mainly in the automotive mould sector and aerospace industry, covering the full milling process from programming to finished part.
Average Trading Volume: 1,364,699
Technical Sentiment Signal: Strong Sell
Current Market Cap: €605.8K
For a thorough assessment of FDA stock, go to TipRanks’ Stock Analysis page.

